Matrix metalloproteinase-2 - The forgotten enzyme in aneurysm pathogenesis

被引:34
|
作者
Thompson, Matt [1 ]
Cockerill, Gillian [1 ]
机构
[1] St George Hosp, Dept Vasc Surg, St Georges Vasc Inst & Acad, London SW17 0RE, England
关键词
metalloproteinase; MMP-2; elastolysis;
D O I
10.1196/annals.1383.034
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The pathogenesis of abdominal aortic aneurysm (AAAs) involves progressive cycles of proteolysis and inflammation, the product of proteolysis driving subsequent inflammation. Little is yet known about the initiating events. We review the specific literature examining the possibility that MMP-2 may be the initial catalyst. Histologically, elastolysis is one of the earliest observable events in aneurysm genesis. Matrix metalloproteinase-2 (MMP-2), as the dominant gelatinase differentially expressed in aneurysmal tissue and cells derived from aneurysms, would be a good candidate. We report the results of in vivo and in vitro experiments, which lend support to the importance of MMP-2 as an aneurysmal initiator.
引用
收藏
页码:170 / 174
页数:5
相关论文
共 50 条
  • [1] Regulation of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Abdominal Aortic Aneurysm
    Wang, Shuo
    Liu, Dan
    Zhang, Xiaolin
    Tian, Xiaoxiang
    CARDIOLOGY DISCOVERY, 2023, 3 (03): : 212 - 220
  • [2] Matrix Metalloproteinase-2 Gene Variants and Abdominal Aortic Aneurysm
    Smallwood, L.
    Warrington, N.
    Allcock, R.
    van Bockxmeer, F.
    Palmer, L. J.
    Iacopetta, B.
    Golledge, J.
    Norman, P. E.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2009, 38 (02) : 169 - 171
  • [3] Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2
    Kimura, Kaoru
    Cheng, Xian Wu
    Nakamura, Kae
    Inoue, Aiko
    Hu, Lina
    Song, Haizhen
    Okumura, Kenji
    Iguchi, Akihisa
    Murohara, Toyoaki
    Kuzuya, Masafumi
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (11) : 1096 - 1101
  • [4] Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection
    Campbell, LG
    Ramachandran, S
    Liu, W
    Shipley, JM
    Itohara, S
    Rogers, JG
    Moazami, N
    Senior, RM
    Jaramillo, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) : 517 - 528
  • [5] The interrelationship of α4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis
    Graesser, D
    Mahooti, S
    Haas, T
    Davis, S
    Clark, RB
    Madri, JA
    LABORATORY INVESTIGATION, 1998, 78 (11) : 1445 - 1458
  • [6] Role of matrix metalloproteinase-2 and 9 in pathogenesis of patients with recurrent pregnancy loss
    Mori, Ryosuke
    Ozaki, Yasuhiko
    Goto, Shinobu
    Ozawa, Fumiko
    Obayashi, Yuki
    Matsukawa, Yasushi
    Kitaori, Tamao
    Sugiura-Ogasawara, Mayumi
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2016, 118 : 132 - 132
  • [7] Matrix metalloproteinase-2 in dentin matrix mineralization
    Satoyoshi, M
    Kawata, A
    Koizumi, T
    Inoue, K
    Itohara, S
    Teranaka, T
    Mikuni-Takagaki, Y
    JOURNAL OF ENDODONTICS, 2001, 27 (07) : 462 - 466
  • [8] Effects of valsartan on matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in atrial fibrillation patients
    裴晓阳
    潘莹
    颜雯
    胡雪松
    SouthChinaJournalofCardiology, 2010, 11 (01) : 15 - 19
  • [9] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
  • [10] Expression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in oral squamous cell carcinomas
    Radhakrishnan, R.
    Shrestha, B.
    Bajracharya, D.
    ORAL ONCOLOGY, 2011, 47 : S84 - S84